palmidrol has been researched along with Brain Injuries in 6 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "in spinal cord and traumatic brain injuries and in age-related pathological processes." | 2.49 | Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries. ( Cuzzocrea, S; Esposito, E, 2013) |
| "Anandamide (AEA) is an endocannabinoid (EC) that modulates multiple functions in the CNS and that is released in areas of injury, exerting putative neuroprotective actions." | 1.42 | Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. ( Cravatt, BF; Hillard, CJ; Koester, EC; Moreno, M; Pazos, MR; Romero, J; Tolón, RM; Vázquez, C, 2015) |
| "Treatment of the middle cerebral artery occlusion (MCAo)-induced animals with PEA reduced edema and brain infractions as evidenced by decreased 2,3,5-triphenyltetrazolium chloride (TTC) staining across brain sections." | 1.38 | Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats. ( Ahmad, A; Crupi, R; Cuzzocrea, S; Esposito, E; Genovese, T; Impellizzeri, D; Marino, A; Velardi, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esposito, E | 5 |
| Cordaro, M | 2 |
| Cuzzocrea, S | 5 |
| Vázquez, C | 1 |
| Tolón, RM | 1 |
| Pazos, MR | 1 |
| Moreno, M | 1 |
| Koester, EC | 1 |
| Cravatt, BF | 1 |
| Hillard, CJ | 1 |
| Romero, J | 1 |
| Impellizzeri, D | 3 |
| Bruschetta, G | 1 |
| Siracusa, R | 1 |
| Crupi, R | 3 |
| Ahmad, A | 2 |
| Campolo, M | 1 |
| Marino, A | 2 |
| Genovese, T | 1 |
| Velardi, E | 1 |
2 reviews available for palmidrol and Brain Injuries
| Article | Year |
|---|---|
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.
Topics: Amides; Animals; Brain; Brain Injuries; Brain Ischemia; Ethanolamines; Humans; Palmitic Acids; Strok | 2014 |
Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries.
Topics: Amides; Animals; Brain Injuries; Endocannabinoids; Ethanolamines; Homeostasis; Humans; Neuroglia; Ne | 2013 |
4 other studies available for palmidrol and Brain Injuries
| Article | Year |
|---|---|
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Topics: Adenosine Triphosphate; Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Apyrase; Arachid | 2015 |
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
Topics: Amides; Animals; Brain Injuries; Cytokines; Ethanolamines; Glial Fibrillary Acidic Protein; Inflamma | 2017 |
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Brain Injuries; Disease Models, | 2012 |
Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats.
Topics: Amides; Animals; Astrocytes; Brain Injuries; Disease Models, Animal; Endocannabinoids; Ethanolamines | 2012 |